Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial - Kahl, S; Gancheva, S; Strassburger, K (Diabetes Care, 2020)
doi:10.2337/dc19-0641